4//SEC Filing
Beck John W 4
Accession 0001209191-12-034768
CIK 0001103390other
Filed
Jun 19, 8:00 PM ET
Accepted
Jun 20, 6:45 PM ET
Size
24.9 KB
Accession
0001209191-12-034768
Insider Transaction Report
Form 4
Beck John W
SVP, Finance & Operations, CFO
Transactions
- Disposition to Issuer
Incentive Stock Option (right to buy)
2012-06-19$8.34/sh−4,503$37,555→ 0 totalExercise: $23.66Exp: 2020-12-13→ Common Stock (4,503 underlying) - Disposition to Issuer
Non-Qualified Stock Option (right to buy)
2012-06-19$17.74/sh−155,952$2,766,588→ 0 totalExercise: $14.26Exp: 2018-05-26→ Common Stock (155,952 underlying) - Disposition to Issuer
Non-Qualified Stock Option (right to buy)
2012-06-19$26.15/sh−6,250$163,438→ 0 totalExercise: $5.85Exp: 2017-06-14→ Common Stock (6,250 underlying) - Disposition to Issuer
Non-Qualified Stock Option (right to buy)
2012-06-19$16.31/sh−12,500$203,875→ 0 totalExercise: $15.69Exp: 2018-01-01→ Common Stock (12,500 underlying) - Disposition to Issuer
Non-Qualified Stock Option (right to buy)
2012-06-19$21.32/sh−44,000$938,080→ 0 totalExercise: $10.68Exp: 2018-12-18→ Common Stock (44,000 underlying) - Disposition to Issuer
Non-Qualified Stock Option (right to buy)
2012-06-19$8.34/sh−15,497$129,245→ 0 totalExercise: $23.66Exp: 2020-12-13→ Common Stock (15,497 underlying) - Disposition to Issuer
Common Stock
2012-06-19$32.00/sh−4,409$141,088→ 0 total - Disposition to Issuer
Non-Qualified Stock Option (right to buy)
2012-06-19$16.31/sh−12,500$203,875→ 0 totalExercise: $15.69Exp: 2018-01-01→ Common Stock (12,500 underlying) - Disposition to Issuer
Incentive Stock Option (right to buy)
2012-06-19$17.05/sh−6,250$106,563→ 0 totalExercise: $14.95Exp: 2019-12-15→ Common Stock (6,250 underlying) - Disposition to Issuer
Non-Qualified Stock Option (right to buy)
2012-06-19$17.05/sh−18,750$319,688→ 0 totalExercise: $14.95Exp: 2019-12-15→ Common Stock (18,750 underlying)
Footnotes (1)
- [F1]This option was canceled pursuant to the Agreement and Plan of Merger, dated as of April 21, 2012, by and among Ardea Biosciences, Inc. ("Ardea"), Zeneca Inc. and QAM Corp. (the "Merger Agreement"), in exchange for a payment in cash, without interest and less the amount of any required tax withholding, equal to the product of: (i) the excess of $32.00 (the per share merger consideration pursuant to the Merger Agreement) over the exercise price of the option; and (ii) the number of shares of Ardea common stock underlying the option.
Documents
Issuer
Ardea Biosciences, Inc./DE
CIK 0001103390
Entity typeother
Related Parties
1- filerCIK 0001292404
Filing Metadata
- Form type
- 4
- Filed
- Jun 19, 8:00 PM ET
- Accepted
- Jun 20, 6:45 PM ET
- Size
- 24.9 KB